This can make it difficult to determine if the medication or the resulting weight loss is the primary trigger
doi: 10.3389/fphar.2025.1528295 Received 14 November 2024 Accepted 28 February 2025 Published 25 March 2025 Volume 16 - 2025 Edited by Manuela Oliverio, Magna Grcia University, Italy Reviewed by Frederic Boal, Metabolic and Cardiovascular Research Institute, France Ren-Lei Ji, Harvard Medical School, United States Updates Copyright 2025 Al-Zaid and Al-Sabah
Lactating individuals considering Lipo-C Injection should discuss risk-benefit considerations with a pediatrician and undergo periodic infant growth monitoring
Presented for research literature review only Ribas V et al
Behav Pharmacol 6 : 6673 Gambarana C, Ghiglieri O, Tagliamonte A, D'Alessandro N, De Montis MG